{"disease":{"id":"transitional-cell-cancer-of-the-renal-pelvis-and-ureter","name":"transitional cell cancer of the renal pelvis and ureter"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04006691","title":"Efficacy and Safety of UGN-101 in Recurrent Patients","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"UroGen Pharma Ltd.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}